Vivace Therapeutics

Vivace Therapeutics develops small molecules targeting the Hippo pathway to treat human carcinomas.

Domain
Healthcare
Status
Current Private Investment
Stage of Initial Investment
Series C
Initial Investment Year
2020
Vivace Hover Image